In vitro studies have shown that TGF- induces a SMAD3-dependent matrix-preserving phenotype in cardiac fibroblasts, which suppresses the synthesis of MMP3 and MMP8 while enhancing the expression of TIMP1[68]
Choosing Between Semaglutide and Tirzepatide for Microdosing From a pharmacology standpoint, semaglutide is a pure GLP-1 receptor agonist , while tirzepatide is a dual GIP/GLP-1 agonist that activates both GIP and GLP-1 receptors.[2,4] That dual mechanism likely contributes to tirzepatides strong weight-loss results at full doses compared with semaglutide in head-to-head and indirect comparisons.[2,7] In the context of microdosing: Some clinicians and patients feel that microdosing tirzepatide provides robust appetite control even at relatively low doses, though this is based largely on real-world experience rather than large trials
This may be days, weeks, or months depending on your pre-existing nutrient and hydration levels, any coinciding illnesses or conditions you have, and your metabolic rate
C.JaeschkeH
It requires daily injection, unlike the weekly dosing of semaglutide